NASDAQ: CLBT
Cellebrite DI Ltd Stock

$10.65-0.47 (-4.23%)
Updated Nov 17, 2026
CLBT Price
$10.65
Fair Value Price
$10.56
Market Cap
$2.66B
52 Week Low
$9.58
52 Week High
$19.39
P/E
40.96x
P/B
4.59x
P/S
5.23x
PEG
0.9x
Dividend Yield
N/A
Revenue
$537.28M
Earnings
$65.23M
Gross Margin
82.3%
Operating Margin
11.86%
Profit Margin
12.1%
Debt to Equity
0.84
Operating Cash Flow
$181M
Beta
0.87
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

CLBT Overview

Cellebrite DI Ltd. delivers specialized digital intelligence solutions crafted for legally authorized investigations. Their comprehensive DI platform enables users to efficiently gather, scrutinize, interpret, and oversee digital information throughout the investigative process. These essential tools are utilized in a wide array of scenarios, including cases involving child exploitation, homicides, counter-terrorism operations, border control, sexual offenses, human trafficking, corporate security incidents, intellectual property theft, and civil litigation. A key offering, the Universal Forensic Extraction Device (UFED), is engineered to surmount significant hurdles in accessing digital evidence, such as intricate device locks, encryption barriers, deleted data, and obscure content that might otherwise conceal crucial information. The company also provides Seeker, designed for analyzing video footage; OSINT Analyze, a real-time deep-dive tool for examining open-source information across the surface, deep, and dark web; and Crypto Tracer, which deciphers blockchain transactions alongside related data from numerous sources to identify and categorize digital wallets and activities. Cellebrite's clientele includes federal, state, and local government bodies, as well as various enterprise companies and service providers. Established in 1999 and headquartered in Petah Tikva, Israel, the firm operates internationally with a footprint in countries such as the United States, Germany, Singapore, Australia, Brazil, the United Kingdom, France, Canada, Japan, and India. Additionally, Cellebrite Mobile Synchronization Ltd. functions as a subsidiary of Sun Corporation.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine CLBT's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +5.11% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Software Infrastructure

Industry Rating
B
CLBT
Ranked
#59 of 127

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$63.55A
$38.60A
$7.44A
View Top Software Infrastructure Stocks

Be the first to know about important CLBT news, forecast changes, insider trades & much more!

CLBT News

Overview

Due Diligence Score

–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CLBT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CLBT ($10.65) is overvalued by 0.83% relative to our estimate of its Fair Value price of $10.56 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
CLBT ($10.65) is not significantly undervalued (0.83%) relative to our estimate of its Fair Value price of $10.56 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CLBT ($10.65) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CLBT due diligence checks available for Premium users.

Valuation

CLBT fair value

Fair Value of CLBT stock based on Discounted Cash Flow (DCF)

Price
$10.65
Fair Value
$10.56
Overvalued by
0.83%
CLBT ($10.65) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CLBT ($10.65) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CLBT ($10.65) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CLBT price to earnings (PE)

For valuing profitable companies with steady earnings

Company
40.96x
Industry
187.06x
Market
39.5x
CLBT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CLBT is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

CLBT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
4.59x
Industry
7.68x
CLBT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CLBT price to earnings growth (PEG)

For valuing profitable companies with growth potential

CLBT is good value based... subscribe to Premium to read more.
PEG Value Valuation

CLBT's financial health

Profit margin

Revenue
$149.0M
Net Income
$26.7M
Profit Margin
17.9%
CLBT's Earnings (EBIT) of $63.75M... subscribe to Premium to read more.
Interest Coverage Financials
CLBT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$1.1B
Liabilities
$489.2M
Debt to equity
0.84
CLBT's short-term assets ($658.41M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CLBT's short-term assets ($658.41M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CLBT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CLBT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$56.6M
Investing
$22.4M
Financing
$2.6M
CLBT's operating cash flow ($180.87M)... subscribe to Premium to read more.
Debt Coverage Financials

CLBT vs Software Infrastructure Stocks

TickerZen RatingMarket Cap1d %P/EP/B
CLBTC$2.66B-4.23%40.96x4.59x
FLYWC$2.61B-3.77%33.32x2.87x
WIXC$2.71B-3.66%-16.67x-1.60x
EEFTC$2.50B-2.10%9.31x1.95x
SPSCB$2.84B-2.03%35.57x3.04x

Cellebrite DI Stock FAQ

What is Cellebrite DI's quote symbol?

(NASDAQ: CLBT) Cellebrite DI trades on the NASDAQ under the ticker symbol CLBT. Cellebrite DI stock quotes can also be displayed as NASDAQ: CLBT.

If you're new to stock investing, here's how to buy Cellebrite DI stock.

What is the 52 week high and low for Cellebrite DI (NASDAQ: CLBT)?

(NASDAQ: CLBT) Cellebrite DI's 52-week high was $19.39, and its 52-week low was $9.58. It is currently -45.07% from its 52-week high and 11.17% from its 52-week low.

How much is Cellebrite DI stock worth today?

(NASDAQ: CLBT) Cellebrite DI currently has 249,475,824 outstanding shares. With Cellebrite DI stock trading at $10.65 per share, the total value of Cellebrite DI stock (market capitalization) is $2.66B.

Cellebrite DI stock was originally listed at a price of $10.07 in Sep 11, 2020. If you had invested in Cellebrite DI stock at $10.07, your return over the last 6 years would have been 5.76%, for an annualized return of 0.94% (not including any dividends or dividend reinvestments).

How much is Cellebrite DI's stock price per share?

(NASDAQ: CLBT) Cellebrite DI stock price per share is $10.65 today (as of Nov 17, 2026).

What is Cellebrite DI's Market Cap?

(NASDAQ: CLBT) Cellebrite DI's market cap is $2.66B, as of Nov 18, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Cellebrite DI's market cap is calculated by multiplying CLBT's current stock price of $10.65 by CLBT's total outstanding shares of 249,475,824.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.